ABI-1968

N/A

Report date: 2025/06/12 20:00:09
NME

Base Information

Drug NameABI-1968
Drug Alias NameABI-1968ODE-Bn-PMEGHTI-1968
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionVirus replication inhibitorsApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsSquamous Intraepithelial LesionsUterine Cervical IncompetenceSquamous Intraepithelial Lesions of the Cervix +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth AfricaAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAntiva Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAntiva Biosciences Inc
Active IndicationsN/A
Inactive IndicationsSquamous Intraepithelial LesionsUterine Cervical IncompetenceSquamous Intraepithelial Lesions of the Cervix +[8] 

Other Information

ATC CodeN/A
Related LinksN/A